References
-
1) Nec-1 alleviated the deleterious effect of CoCl2 on C2C12 myoblast differentiation and fusion via the mTOR pathway.
Product: MYF5 Antibody (#DF3089)Year: 2022Journal: TISSUE CELLImpactFactor: 2.7DOI: 10.1016/j.tice.2022.101910PMID: 36081319 -
2) DNA Methylation-Mediated GPX4 Transcriptional Repression and Osteoblast Ferroptosis Promote Titanium Particle-Induced Osteolysis.
Product: SKIL Antibody (#DF3088)Year: 2024Journal: Research (Wash D C)ImpactFactor: 11DOI: 10.34133/research.0457PMID: 39161535 -
3) An Fgr kinase inhibitor attenuates sepsis-associated encephalopathy by ameliorating mitochondrial dysfunction, oxidative stress, and neuroinflammation via the SIRT1/PGC-1α signaling pathway.
Product: FGR Antibody (#DF3081)Year: 2023Journal: J Transl MedImpactFactor: 7.4DOI: 10.1186/s12967-023-04345-7PMID: 37475042 -
4) Expression Profiles of HOXC6 Predict the Survival of Glioblastoma Patients and Correlate with Cell Cycle.
Product: HOXC6 Antibody (#DF3078)Year: 2022Journal: J ONCOLDOI: 10.1155/2022/8656865PMID: 35432534 -
5) The role of dendritic cells regulated by HMGB1/TLR4 signalling pathway in myocardial ischaemia reperfusion injury.
Product: HMGB1 Antibody (#DF3077)Year: 2019Journal: J CELL MOL MEDImpactFactor: 5.3DOI: 10.1111/jcmm.14192PMID: 30784177 -
6) Sympathetic Denervation Ameliorates Renal Fibrosis via Inhibition of Cellular Senescence.
-
7) Histone Acetyltransferase Mof Affects the Progression of DSS-Induced Colitis.
Product: MYST2 Antibody (#DF3056)Year: 2018Journal: CELL PHYSIOL BIOCHEMImpactFactor: 2.5DOI: 10.1159/000491527PMID: 29975939 -
8) TL1A/DR3 Axis, A Key Target of TNF-a, Augments the Epithelial–Mesenchymal Transformation of Epithelial Cells in OVA-Induced Asthma.
Product: TNFSF15 Antibody (#DF3053)Year: 2022Journal: FRONT IMMUNOLImpactFactor: 5.7DOI: 10.3389/fimmu.2022.854995PMID: 35359966 -
9) The TL1A-DR3 Axis in Asthma: Membrane-Bound and Secreted TL1A Co-Determined the Development of Airway Remodeling.
Product: TNFSF15 Antibody (#DF3053)Year: 2022Journal: ALLERGY ASTHMA IMMUNImpactFactor: 4.1DOI: 10.4168/aair.2022.14.2.233PMID: 35255540 -
10) Overexpression of Tumor Necrosis Factor-Like Ligand 1 A in Myeloid Cells Aggravates Liver Fibrosis in Mice.
Product: TNFSF15 Antibody (#DF3053)Year: 2019Journal: J IMMUNOL RESImpactFactor: 3.5DOI: 10.1155/2019/7657294PMID: 30906791 -
11) A Crucial Angiogenesis-Associated Gene MEOX2 Could Be a Promising Biomarker Candidate for Breast Cancer.
Product: MEOX2 Antibody (#DF3192)Year: 2022Journal: FRONT ONCOLImpactFactor: 3.5DOI: 10.3389/fonc.2022.759300PMID: 35615155 -
12) HOXA1 participates in VSMC-to-macrophage-like cell transformation via regulation of NF-κB p65 and KLF4: a potential mechanism of atherosclerosis pathogenesis.
Product: HOXA1 Antibody (#DF3187)Year: 2023Journal: Mol MedImpactFactor: 6DOI: 10.1186/s10020-023-00685-8PMID: 37528397 -
13) Free fatty acid receptor 4 deletion attenuates colitis by modulating Treg Cells via ZBED6-IL33 pathway.
Product: HOXA1 Antibody (#DF3187)Year: 2022Journal: EBIOMEDICINEImpactFactor: 9.7DOI: 10.1016/j.ebiom.2022.104060PMID: 35525203 -
14) MiR-382-5p suppresses M1 macrophage polarization and inflammatory response in response to bronchopulmonary dysplasia through targeting CDK8: Involving inhibition of STAT1 pathway.
Product: CDK8 Antibody (#DF3186)Year: 2021Journal: GENES CELLSImpactFactor: 1.3DOI: 10.1111/gtc.12883PMID: 34228857 -
15) Engineered bone marrow mesenchymal stem cell-derived exosomes loaded with miR302 through the cardiomyocyte specific peptide can reduce myocardial ischemia and reperfusion (I/R) injury.
Product: YAP Antibody (#DF3182)Year: 2024Journal: J Transl MedImpactFactor: 7.4DOI: 10.1186/s12967-024-04981-7PMID: 38368334